Mannkind corp (MNKD)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-9,322

-14,263

-10,370

-12,387

-14,883

-9,751

-24,164

-22,675

-30,385

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-16,324

-

126,521

-29,958

-24,873

-277,019

-31,857

-28,911

-30,658

-36,441

-36,519

-73,366

-52,056

Adjustments to reconcile net loss to net cash used in operating activities:
Impairment of commitment asset

1,521

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation expense

1,128

891

1,640

2,673

999

1,142

1,563

2,209

1,943

1,084

1,247

1,249

1,267

1,005

1,502

1,355

1,273

2,347

2,600

1,775

2,003

1,867

-4,828

40,646

10,937

Depreciation, amortization and accretion

538

565

-332

372

367

368

1,030

753

706

821

920

879

908

1,061

1,039

1,035

1,023

3,182

3,735

3,371

2,988

3,001

2,960

3,220

9,394

(Gain) loss on extinguishment of debt

-

-

-

-

-

0

-712

772

-825

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of right-of-use assets

282

279

285

223

395

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest on note payable to principal stockholder

-

-

-

-

-

-

-

-

-

-

-

-

-

-

729

722

721

-

-

-

-

-

-

-

-

Gain on foreign currency translation

1,796

-2,582

3,807

-1,247

1,935

1,361

728

5,363

-2,984

-1,564

-3,685

-6,847

-1,545

6,468

-1,012

341

-2,364

-

-

-

-

-

-

-

-

Interest expense on promissory notes

1,257

-

-

-

1,134

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest incurred through borrowings under Sanofi Loan Facility

-

-

-

-

-

-

-

-

-

-

-

-

-

353

1,521

1,436

1,168

854

533

232

33

-

-

-

-

Interest on note payable to related party

-

-

-

-

-

-

-

1,097

1,122

1,174

1,173

721

714

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-1,288

147

6,629

-

-

-

-

-

-

-

-

-

-

-

-

Write-off of inventory

496

0

0

0

0

420

1,013

177

602

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other, net

-19

-

-

-

-104

141

0

4

-110

-

-

-

-

698

0

-21

-696

-

-1

-1

7

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable, net

1,661

-580

-881

1,215

-258

1,265

-96

1,298

-1,128

985

492

874

136

-2,812

3,137

-144

121

-

-

-

-

-

-

-

-

Receivable from Sanofi

-

-

-

-

-

-

-

-

-

0

0

0

-30,557

-

-

-

-

-

-

-

-

-

-

-

-

Inventory

-428

463

-271

243

123

1,232

122

-38

1,836

706

290

934

1,367

-

-

-

-

12,702

3,586

3,027

7,119

-

-

-

-

Receivable from collaboration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

466

-46,154

-

-

-

-

Deferred costs from commercial product sales

-

-

-

-

-

-

-

-

-

-138

43

28

163

-

-

-

-

-

-

-

-

-

-

-

-

Deferred costs from collaboration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

2,708

4,580

6,251

-

-

-

-

Prepaid expenses and other current assets

-988

-695

878

314

-164

-459

445

216

-656

-51

497

-944

-856

-170

3,111

-1,384

-1,211

-6,502

-849

-2,299

-3,831

-34

16,557

56

-1,845

Right-of-use and other assets

-

-

-

-

-

-

121

41

38

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

-40

-

-

-

340

-

-

-

-

-22

-41

-86

-39

-54

-545

152

86

-822

-194

-6

872

-280

599

214

82

Accounts payable

1,942

-6,875

4,128

555

1,599

-436

-3,422

4,261

-2,008

1,701

-1,258

5,022

-1,665

-1,830

2,244

2,267

-14,799

11,111

-462

1,946

-4,182

-10,070

12,125

2,605

-1,038

Accrued expenses and other current liabilities

1,880

3,632

-594

-1,876

2,336

1,689

-258

-1,857

2,675

43

3,372

-1,560

1,077

-6,227

3,912

2,175

488

-6,545

1,878

2,860

-10,660

5,279

312

3,389

-6,704

Deferred revenue

-8,235

6,004

-5,926

-7,481

686

34,831

9,934

2,112

-63

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities

-724

-

-

-

-395

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Recognized loss on purchase commitments

-

0

-411

-2,021

-1,963

-774

-365

-5,653

-147

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

429

748

-1,575

-

-

-

-

-

-

5,918

7,050

-

-

-

-

Deferred payments from collaborations

-

-

-

-

-

-

-

-

-

-

-62

-62

-63

-

-144,435

9,202

177

-

-

-

-

-

-

-

-

Recognized loss on purchase commitments

-

-

-

-

-

-

-

-

-

-

-148

34

-534

-

-

-

-

-

-

-

-

-

-

-

-

Milestone rights liability and other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-680

710

-2,165

751

721

714

Net cash (used in) provided by operating activities

-

-

-

-

-

-

-

-

-

-

-

-

8,507

-

-23,071

-11,509

-30,758

-22,551

-19,892

-17,809

3,020

-35,744

100,238

-23,418

-36,990

Net cash used in operating activities

-11,219

-5,107

-52,051

-19,728

-11,597

24,988

-13,919

-27,150

-21,650

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment

150

109

963

1,224

269

-

-

-

-

-

-

-

-

0

0

0

1,144

316

1,232

4,534

4,203

4,963

9,467

8,258

1,409

Purchase of treasury bills

-

91

19,971

145

24,764

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of treasury bills

20,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net proceeds from sale of asset held for sale

-

-

-

-

-

-

-

-

-

0

0

0

16,651

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

17

-

-

-

-

-

-

-

-

Net cash provided by (used in) investing activities

19,850

-202

3,761

-1,369

-25,033

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

38

267

467

-9,378

704

6,652

6,168

-

-

17,221

3,401

Milestone payment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-1

0

4,220

-

-

-

-

Exercise of stock options

8

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of employment taxes related to vested restricted stock units

325

-

-

-

-

-

0

103

81

17

22

13

75

4

158

0

3

25

1,015

56

762

64

26,721

90

33

Net cash provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

-

16,651

-

0

0

-1,127

-312

-1,154

-4,534

-4,203

-14,213

-217

-8,258

-1,409

Other

-

-

-

-

3

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-75

-

-5,132

47,589

464

49,009

-53,213

8,686

1,186

-1,667

31,230

37,131

3,368

NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH

-

-

-

-

-

-

-

-

-

-

-

-

25,083

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

331

5,042

65,495

-676

3

35,967

-1,823

26,622

528

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH

8,962

-267

17,205

-21,773

-36,627

60,711

-15,732

-528

-21,122

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

NET DECREASE IN CASH AND CASH EQUIVALENTS

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-28,203

36,080

-31,421

-

-74,259

-13,657

3

-51,624

131,251

5,455

-35,031

SUPPLEMENTAL CASH FLOWS DISCLOSURES:
Interest paid in cash, net of amounts capitalized

885

-

-

-

-

864

1,035

0

1,860

1,355

2,232

1,591

2,550

1,793

2,590

1,895

2,713

-

-

-

-

-

-

-

-

Interest paid in cash, net of amounts capitalized to construction in progress

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,749

1,478

4,444

618

4,678

NON-CASH INVESTING AND FINANCING ACTIVITIES:
Common stock issuance to settle employee stock purchase plan liability

318

0

339

0

317

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Tranche B Commitment Asset

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-1,168

2,921

Payment of senior convertible notes through common stock issuance

-

-

-

-

-

-37,912

22,507

10,998

9,407

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

86,000

Payment of interest on senior convertible notes through common stock issuance

144

0

537

4

534

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash construction in progress and property and equipment

32

-

-587

544

246

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Addition of right-of-use assets upon adoption of new lease guidance

-

0

0

0

5,192

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of note payable to related party through common stock issuance

-

-

-

-

-

-

-

0

8,160

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued but unpaid debt issuance costs

-

-

-

-

-

-

-10

81

75

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash construction in progress and property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

558

-

-431

-471

1,094

-2,041

844

1,265

1,700

At The Market Issuance
Proceeds from at-the-market offering

668

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock pursuant to at-the-market offering

-

-

-

-

-

-

185

0

634

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance costs associated with at-the-market offering

20

-

-

-

-

51

8

0

25

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-